Senseonics (NASDAQ:SENS – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday, Wall Street Zen reports.
Other equities analysts have also recently issued reports about the stock. Mizuho lifted their target price on shares of Senseonics from $18.00 to $20.00 and gave the company an “outperform” rating in a report on Tuesday, November 10th. HC Wainwright restated a “buy” rating and issued a $14.00 price objective on shares of Senseonics in a research note on Tuesday, November 10th. Barclays lifted their price objective on shares of Senseonics from $10.00 to $11.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 10th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $10.00 target price (up from $9.00) on shares of Senseonics in a report on Tuesday, November 10th. Finally, Raymond James Financial upgraded shares of Senseonics from an “underperform” rating to a “market perform” rating in a research note on Tuesday, November 10th. Three equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $14.40.
Read Our Latest Stock Analysis on SENS
Senseonics Stock Performance
NASDAQ:SENS opened at $10.58 on Friday. The stock’s 50 day moving average price is $9.17 and its 200 day moving average price is $7.33. The company has a market capitalization of $442.28 million, a PE ratio of -4.60 and a beta of 1.04. The company has a quick ratio of 5.60, a current ratio of 5.92 and a debt-to-equity ratio of 0.70. Senseonics has a 52-week low of $4.79 and a 52-week high of $13.98.
Senseonics (NASDAQ:SENS – Get Free Report) last issued its quarterly earnings data on Monday, November 9th. The company reported ($0.50) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.01). Senseonics had a negative net margin of 204.01% and a negative return on equity of 186.11%. The firm had revenue of $19.56 million during the quarter. On average, research analysts anticipate that Senseonics will post -2.20 EPS for the current year.
Insiders Place Their Bets
In other Senseonics news, Director Douglas Roeder acquired 13,953 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The shares were purchased at an average price of $8.98 per share, with a total value of $125,297.94. Following the completion of the acquisition, the director directly owned 171,191 shares of the company’s stock, valued at approximately $1,537,295.18. The trade was a 8.87% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 4.70% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Senseonics
A number of hedge funds and other institutional investors have recently bought and sold shares of SENS. Empowered Funds LLC purchased a new stake in shares of Senseonics during the 3rd quarter worth $621,000. Ieq Capital LLC acquired a new position in shares of Senseonics during the 3rd quarter worth $215,000. StoneX Group Inc. purchased a new position in shares of Senseonics in the 3rd quarter valued at about $128,000. Traynor Capital Management Inc. purchased a new position in shares of Senseonics in the 3rd quarter valued at about $152,000. Finally, State of Wyoming increased its holdings in shares of Senseonics by 27.2% in the 3rd quarter. State of Wyoming now owns 14,940 shares of the company’s stock valued at $152,000 after purchasing an additional 3,199 shares in the last quarter. Institutional investors and hedge funds own 12.36% of the company’s stock.
Key Headlines Impacting Senseonics
Here are a few of the latest headlines about SENS:
- Positive Sentiment: Mizuho and Barclays issued forecasts pointing to potential price appreciation, and TD Cowen raised its price target. These positive calls may bolster investor confidence. Mizuho forecast Barclays forecast TD Cowen price-target update
- Neutral Sentiment: Stifel Nicolaus assigned a Hold rating, while Raymond James upgraded SENS to Market Perform. These stances are more cautious than a Buy recommendation but do not signal an outright bearish view. Stifel rating Raymond James rating
- Negative Sentiment: HC Wainwright lowered several 2026–2027 quarterly EPS forecasts and its FY2027 estimate, reflecting expectations of larger losses in those periods. This tempers the positive longer-term revisions. HC Wainwright earnings estimate revisions
About Senseonics
Senseonics Holdings, Inc. develops continuous glucose monitoring (CGM) technology for people with diabetes. Its Eversense systems use a small sensor implanted under the skin to measure glucose levels, an external wearable transmitter to send readings, and a mobile app to display data and provide alerts. The company’s product line includes implantable CGM systems designed for extended wear, including the Eversense 365 system, which is designed to last up to one year. Unlike many CGM products that use sensors replaced more frequently, Eversense sensors are inserted and removed by a healthcare professional.
Further Reading
- Five stocks we like better than Senseonics
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.
